The HDAC inhibitor SAHA regulates CBX2 stability via a SUMO-triggered ubiquitin-mediated pathway in leukemia

[1]  L. Altucci,et al.  Erratum: miR-194-5p/BCLAF1 deregulation in AML tumorigenesis , 2017, Leukemia.

[2]  P. Dijke,et al.  SUMO-triggered ubiquitination of NR4A1 controls macrophage cell death , 2017, Cell Death and Differentiation.

[3]  R. Gordân,et al.  HDAC inhibitors cause site-specific chromatin remodeling at PU.1-bound enhancers in K562 cells , 2016, Epigenetics & Chromatin.

[4]  K. Nakano,et al.  Polycomb-dependent epigenetic landscape in adult T-cell leukemia. , 2016, Blood.

[5]  W. Lam,et al.  Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancer , 2016, Clinical Epigenetics.

[6]  H. Stunnenberg,et al.  Non-canonical PRC1.1 Targets Active Genes Independent of H3K27me3 and Is Essential for Leukemogenesis. , 2016, Cell reports.

[7]  A. Vertegaal,et al.  SUMOylation-Mediated Regulation of Cell Cycle Progression and Cancer. , 2015, Trends in biochemical sciences.

[8]  Ruiwen Zhang,et al.  Polycomb Group (PcG) Proteins and Human Cancers: Multifaceted Functions and Therapeutic Implications , 2015, Medicinal research reviews.

[9]  J. Enserink,et al.  Sumo and the cellular stress response , 2015, Cell Division.

[10]  Zhongyi Cheng,et al.  Suberoylanilide Hydroxamic Acid Treatment Reveals Crosstalks among Proteome, Ubiquitylome and Acetylome in Non-Small Cell Lung Cancer A549 Cell Line , 2015, Scientific Reports.

[11]  V. Stojanoff,et al.  Small-molecule modulators of methyl-lysine binding for the CBX7 chromodomain. , 2015, Chemistry & biology.

[12]  W. Lam,et al.  Genotranscriptomic meta-analysis of the Polycomb gene CBX2 in human cancers: initial evidence of an oncogenic role , 2014, British Journal of Cancer.

[13]  J. Wulff,et al.  Chromodomain antagonists that target the polycomb-group methyllysine reader protein chromobox homolog 7 (CBX7). , 2014, Journal of medicinal chemistry.

[14]  Jie Li,et al.  Cbx4 governs HIF-1α to potentiate angiogenesis of hepatocellular carcinoma by its SUMO E3 ligase activity. , 2014, Cancer cell.

[15]  M. Scharfe,et al.  SUMOylation of the polycomb group protein L3MBTL2 facilitates repression of its target genes , 2013, Nucleic acids research.

[16]  Y. Schwartz,et al.  A new world of Polycombs: unexpected partnerships and emerging functions , 2013, Nature Reviews Genetics.

[17]  K. Helin,et al.  Transcriptional regulation by Polycomb group proteins , 2013, Nature Structural &Molecular Biology.

[18]  S. Um,et al.  CBX8 suppresses Sirtinol-induced premature senescence in human breast cancer cells via cooperation with SIRT1. , 2013, Cancer letters.

[19]  G. Viglietto,et al.  Nonredundant and locus-specific gene repression functions of PRC1 paralog family members in human hematopoietic stem/progenitor cells. , 2013, Blood.

[20]  Anthony A. Hyman,et al.  Stoichiometry of chromatin-associated protein complexes revealed by label-free quantitative mass spectrometry-based proteomics , 2012, Nucleic acids research.

[21]  S. Armstrong,et al.  Polycomb repressive complex 2 is required for MLL-AF9 leukemia , 2012, Proceedings of the National Academy of Sciences.

[22]  Marie-christine Caron,et al.  CBX4-mediated SUMO modification regulates BMI1 recruitment at sites of DNA damage , 2012, Nucleic acids research.

[23]  Ji Luo,et al.  A SUMOylation-Dependent Transcriptional Subprogram Is Required for Myc-Driven Tumorigenesis , 2012, Science.

[24]  S. Puig,et al.  A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma , 2011, Nature.

[25]  R. Kingston,et al.  Compaction of chromatin by diverse Polycomb group proteins requires localized regions of high charge. , 2011, Genes & development.

[26]  L. D. Croce,et al.  Roles of the Polycomb group proteins in stem cells and cancer , 2011, Cell Death and Disease.

[27]  A. Pollice,et al.  A dominant mutation etiologic for human tricho‐dento‐osseous syndrome impairs the ability of DLX3 to downregulate ΔNp63α , 2011, Journal of cellular physiology.

[28]  Shili Duan,et al.  Recognition and Specificity Determinants of the Human Cbx Chromodomains* , 2010, The Journal of Biological Chemistry.

[29]  Edward T H Yeh,et al.  SUMO Losing Balance: SUMO Proteases Disrupt SUMO Homeostasis to Facilitate Cancer Development and Progression. , 2010, Genes & cancer.

[30]  K. Nakayama,et al.  Phosphorylation of the chromodomain changes the binding specificity of Cbx2 for methylated histone H3. , 2010, Biochemical and biophysical research communications.

[31]  J. Voncken,et al.  Talking to chromatin: post-translational modulation of polycomb group function , 2009, Epigenetics & Chromatin.

[32]  M. Tatham,et al.  Detection of protein SUMOylation in vivo , 2009, Nature Protocols.

[33]  K. Helin,et al.  The Polycomb Repressive Complex 2 Is a Potential Target of SUMO Modifications , 2008, PloS one.

[34]  Erik Meulmeester,et al.  Mechanism and consequences for paralog-specific sumoylation of ubiquitin-specific protease 25. , 2008, Molecular cell.

[35]  M. Lei,et al.  Arsenic degrades PML or PML–RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway , 2008, Nature Cell Biology.

[36]  Erica S. Johnson,et al.  Ubiquitin-dependent Proteolytic Control of SUMO Conjugates* , 2007, Journal of Biological Chemistry.

[37]  J. Zhao,et al.  Sumoylation regulates diverse biological processes , 2007, Cellular and Molecular Life Sciences.

[38]  Masahide Takahashi,et al.  Polycomb protein Cbx4 promotes SUMO modification of de novo DNA methyltransferase Dnmt3a. , 2007, The Biochemical journal.

[39]  M. Lohuizen,et al.  Stem Cells and Cancer The Polycomb Connection , 2004, Cell.

[40]  L. Ngo,et al.  Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[41]  M. Kagey,et al.  The Polycomb Protein Pc2 Is a SUMO E3 , 2003, Cell.

[42]  Hengbin Wang,et al.  Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing , 2002, Science.

[43]  M. van Lohuizen,et al.  Polycomb repression: from cellular memory to cellular proliferation and cancer. , 2002, Biochimica et biophysica acta.

[44]  H. Saitoh,et al.  Functional Heterogeneity of Small Ubiquitin-related Protein Modifiers SUMO-1 versus SUMO-2/3* , 2000, The Journal of Biological Chemistry.

[45]  Mary Anne Wheeler,et al.  Stem , 1985 .

[46]  R. Roeder,et al.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. , 1983, Nucleic acids research.

[47]  A. Fusco,et al.  CBX7 is a tumor suppressor in mice and humans. , 2012, The Journal of clinical investigation.

[48]  R. Vento,et al.  The role of oxidative stress in apoptosis induced by the histone deacetylase inhibitor suberoylanilide hydroxamic acid in human colon adenocarcinoma HT-29 cells. , 2008, International journal of oncology.